Masanobu Kano Selected Research

Cerebellar Diseases (Cerebellar Syndrome)

1/2021	mGluR1 signaling in cerebellar Purkinje cells: Subcellular organization and involvement in cerebellar function and disease.
1/2018	Type 1 metabotropic glutamate receptor and its signaling molecules as therapeutic targets for the treatment of cerebellar disorders.
1/2017	Type-1 metabotropic glutamate receptor signaling in cerebellar Purkinje cells in health and disease.
12/2002	mGluR1 in cerebellar Purkinje cells is required for normal association of temporally contiguous stimuli in classical conditioning.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masanobu Kano Research Topics

Disease

4	Seizures (Absence Seizure) 01/2021 - 06/2014
4	Cerebellar Diseases (Cerebellar Syndrome) 01/2021 - 12/2002
3	Schizophrenia (Dementia Praecox) 01/2021 - 01/2012
3	Autistic Disorder (Autism) 01/2021 - 06/2014
3	Tuberous Sclerosis (Bourneville's Disease) 01/2021 - 06/2014
3	Epilepsy (Aura) 01/2021 - 05/2015
3	Ataxia (Dyssynergia) 01/2021 - 12/2002
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 06/2014
3	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2018 - 06/2002
3	Neoplasms (Cancer) 01/2013 - 06/2009
2	Autism Spectrum Disorder 01/2021 - 01/2017
2	Pain (Aches) 09/2014 - 02/2014
2	Atrophy 06/2014 - 02/2009
2	Sarcoma (Soft Tissue Sarcoma) 01/2013 - 08/2011
2	Cognitive Dysfunction 12/2009 - 07/2009
1	Lennox Gastaut Syndrome 01/2021
1	Myoclonic Epilepsies (Myoclonic Encephalopathy) 01/2021
1	Drug Resistant Epilepsy 01/2021
1	Craniosynostoses (Craniosynostosis) 01/2020
1	Partial Epilepsies (Epilepsy, Partial) 01/2020
1	Neuroinflammatory Diseases 10/2019
1	Obesity 01/2019
1	Bradycardia 07/2018
1	Bundle-Branch Block (Fascicular Block) 07/2018
1	Frontotemporal Dementia (Semantic Dementia) 01/2018
1	Temporal Lobe Epilepsy 01/2018
1	Autoimmune Diseases (Autoimmune Disease) 01/2018
1	Status Epilepticus (Complex Partial Status Epilepticus) 01/2016
1	Fever (Fevers) 01/2015
1	Hypokalemia 01/2015
1	Hypertrophy 06/2014
1	Sclerosis 06/2014
1	Microcephaly 06/2014
1	Synovial Sarcoma (Synovioma) 09/2012
1	Acrocephalopolydactylous Dysplasia 04/2011
1	Griscelli syndrome type 1 04/2011
1	Nervous System Diseases (Neurological Disorders) 04/2011
1	Dementia (Dementias) 12/2009

Drug/Important Bio-Agent (IBA)

7	EndocannabinoidsIBA 01/2021 - 02/2014
4	metabotropic glutamate receptor type 1IBA 01/2021 - 12/2002
4	Monoacylglycerol LipasesIBA 10/2019 - 09/2014
4	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2019 - 09/2014
4	EnzymesIBA 01/2019 - 09/2014
4	glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA 01/2019 - 09/2014
3	CannabinoidsIBA 01/2021 - 05/2015
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2019 - 06/2014
2	Glutamic Acid (Glutamate)FDA Link 01/2018 - 01/2012
2	polyglutamineIBA 01/2017 - 02/2009
2	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 01/2016 - 01/2015
2	AntigensIBA 01/2013 - 06/2009
2	Proteins (Proteins, Gene)FDA Link 01/2013 - 06/2002
2	Protein Subunit VaccinesIBA 09/2012 - 06/2009
2	Mutant Proteins (Protein, Mutant)IBA 02/2009 - 06/2002
1	Arginine (L-Arginine)FDA Link 01/2021
1	neuroligin 3IBA 01/2021
1	Vitamin B 6IBA 01/2021
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2021
1	Amino Acids FDA Link 01/2021
1	CannabidiolIBA 01/2021
1	NeuroliginsIBA 01/2021
1	Histone MethyltransferasesIBA 01/2020
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2020
1	MSX2 proteinIBA 01/2020
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2019
1	LipidsIBA 01/2019
1	Hyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsIBA 07/2018
1	ProgranulinsIBA 01/2018
1	AutoantibodiesIBA 01/2018
1	gamma-Aminobutyric Acid (GABA)IBA 01/2018
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2018
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018
1	Protein Isoforms (Isoforms)IBA 01/2017
1	RNA Splice SitesIBA 01/2017
1	Serotonin (5 Hydroxytryptamine)IBA 01/2017
1	Codon (Codons)IBA 01/2017
1	Kainic Acid (Kainate)IBA 01/2016
1	Phospholipases (Phospholipase)IBA 01/2015
1	Anti-Arrhythmia AgentsIBA 01/2015
1	LipopolysaccharidesIBA 01/2015
1	Dinoprostone (PGE2)FDA Link 01/2015
1	AM 251 (AM251)IBA 09/2014
1	JZL 184IBA 09/2014
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 09/2014
1	Analgesics (Analgesic Drugs)IBA 09/2014
1	Acetic Acid (Vinegar)FDA LinkGeneric 09/2014
1	Formaldehyde (Formol)FDA Link 09/2014
1	trans-sodium crocetinate (crocetin)IBA 06/2014
1	TOR Serine-Threonine KinasesIBA 06/2014
1	ProstaglandinsIBA 02/2014
1	Messenger RNA (mRNA)IBA 01/2013
1	Biomarkers (Surrogate Marker)IBA 01/2013
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2012
1	N-Methylaspartate (NMDA)IBA 01/2012
1	Myosins (Myosin)IBA 04/2011
1	Amyloid beta-PeptidesIBA 12/2009
1	Antihypertensive Agents (Antihypertensives)IBA 12/2009
1	Angiotensin Receptor AntagonistsIBA 12/2009
1	olmesartanIBA 12/2009

Therapy/Procedure

2	Immunotherapy 08/2011 - 06/2009
1	Therapeutics 01/2013